AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$29.60
+1.25 (+4.41%)
Open$28.79
Previous Close$28.35
Day High$30.17
Day Low$28.59
52W High$46.00
52W Low$22.24
Volume—
Avg Volume838.2K
Market Cap1.70B
P/E Ratio—
EPS$-6.96
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-63.3% upside
Current
$29.60
$29.60
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.25M | 51.13M | 198.27M |
| Net Income | 687.60M | 849.47M | -11,344,752 |
| Profit Margin | 1,845.9% | 1,753.6% | -5.7% |
| EBITDA | 689.45M | 899.08M | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | -27.2% | -27.2% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |